SKLB70326 T26194
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
SKLB70326 is a cell-cycle progression inhibitor that acts by inducing G0/G1 phase arrest and apoptosis in human hepatic carcinoma cells.
CAS nr:
1257317-77-3
Purity:
98%
Molecular Weight:
299,34
SMILES:
O=C(C1=C(N)C2=CC=C(C3=CC=CC(OC)=C3)N=C2S1)N
Formula:
C15H13N3O2S
Pathway:
Target:
